chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child inadvertently received 2 doses of flu mist within minutes of each other. The order for administration of flumist was sent electronically to both the medical assistant and the RN (me) working in the sick clinic. After I received the order for the flumist, I entered the patient's room and advised mother that the child was receiving flumist. I verified child's name and date of birth and reviewed the screening questions with the mother of the child. All answers were negative for contraindications, mother signed the screening form. Flumist was administered to the child and the mother then requested a school note. Upon returning to the room with the school note, Dr was in the room. At that time it was discovered that the child had received the flumist minutes before, administered by the medical assistant. Mother did not inform me that the child had already received the flumist. The mother had completed the screening questionaire prior to the first dose of flumist also. Child received 2 doses of flumist within minutes of each other. Mother was counseled to return to office or seek medical attention for any adverse effects. No medical treatment was provided. Dr spoke with mother on 10/04/19. Mother stated child was in her usual state of health.
1 wk after developed low grade fever w/emotional outbursts that lasted for apx. 1 week.
large area of induration, warmth,erythema,swelling temp 99.3 oral. Augmentin 600mg bid x 10 days tylenol/motrin prn, warm compresses to site
Diarrhea, significant abdominal pain/irritability concerning for intussusception (US was negative however), hospitalization overnight 10/22 given irritability and pain
Member complains of "severe itching" from head to toe. Member given Benadryl + Clairton by  Doctor.
Within a day of vaccine: sore upper arm,  slight lump near injection area  6 days after vaccine:large red blotch around injection area and it was itching.
Patient developed nausea, chest pain, and difficulty breathing on 01APR. Presented to clinic on 05APR and EKG showed diffuse ST elevation, went sent to the ER. Troponins, CK and CKMB were all elevated. Echo was obtained. Patient diagnosed with perimyocarditis with pericardial effusion.
Fever for 36 hours even with use of Tylenol. Fever prior to Tylenol was recorded at 102.6. Fever post Tylenol 100.8.; Racing heart rate recorded at 120 bpm; Severe chills; body ache; muscle and bone pain; muscle and bone pain; Shooting pains in various joints; Brief stomach pain; Sore axillary lymph node on side of injection arm; Sore arm at injection; dizziness; weakness; This is a spontaneous report from a non-contactable other HCP. A 31-year-old female patient received BNT162b2 (lot: EK9231), via an unspecified route of administration on 08Jan2021 at single dose for covid-19 immunization. Medical history included covid (Previous covid was diagnosed with serology antibody test in doctors office. Not diagnosed with a covid test). The patient's concomitant medications were not reported. Fever for 36 hours even with use of Tylenol. Fever prior to Tylenol was recorded at 102.6 (Jan2021). Fever post Tylenol 100.8 (Jan2021). Racing heart rate recorded at 120 bpm (08Jan2021). Severe chills and body ache, including muscle and bone pain. Shooting pains in various joints. Brief stomach pain. Sore axillary lymph node on side of injection arm. Sore arm at injection site began 3/4 hours post injection (08Jan2021). All other symptoms began 11 hours post injection (08Jan2021). Continued dizziness and weakness 56 hours post injection (Jan2021). The patient was not pregnant at the time of vaccination. The outcome of the events was Resolved with Sequel in Jan2021.  No follow-up attempts are possible. No further information is expected.
Approximately 7 days after injection developed itching and redness in vaccinated arm approximately 3-5? below shot site.  Over the course of 3 days redness increased fro 2x3? to 3x6?, redness decreasing in intensity but itching remained the same.  Was not hot to the touch, and no other untoward effects were noted either at the time of the shot (other then some local soreness at the site and some tenderness to the touch at the medial area of the arm where rash  eventually appeared) or since.  Hydrocortisone was applied 3x?s day for 2 days,  25 mg. Benadryl taken  one time hs.  All resolved in approximately 5-7 days.  At routine physical 3 wks. post shot, consulted with  PCP, showing pictures of area..  He concurred that reasonable to get booster scheduled for 3/5/2021.
cough, paresthesia - Information has been received from a physician concerning a female patient who in March 2001, was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation site not reported.  In march 2001, the patient experienced a cough and tingling and burning sensation.  No further information is available.
2DEC91 pt recvd Engerix-B & on recvd needlestick on 2DEC91; on 3DEC91 & on 8DEC91 devel dizziness & felt like would fall down did not lose consciousness; 48 hrs post vax near syncope w/o loss of consciousness, dizziness & lightheadedness;
Patient started having extreme tremors starting Sunday, 2 days after receiving the second dose.  She had to take Ativan to lessen the effects of the tremors on Monday.  This also happened with the first dose and did not fully recover.  It was really severe on Sunday and Monday was more tolerable.  Upon physical exam, the tremor is pronounced and effected daily activity
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 84-year-old female patient received BNT162b2 (BNT162B2), on 04Mar2021 at 12:00 as dose 1, single (Lot number: EL9266), in right arm, on 01Apr2021 at 12:00 as dose 2, single (Lot number: ER8733), in left arm, on 13Oct2021 at 15:00 as dose 3 (booster), single (Lot number: FF2589), in left arm and on 26Mar2022 at 14:00 as dose 4 (booster), single (Lot number: FM0698) at the age of 82 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "Sjogren's syndrome" (unspecified if ongoing); "coronary artery disease" (unspecified if ongoing); "macular degeneration" (unspecified if ongoing). Concomitant medication(s) (other medications in 2 weeks) included: ATORVASTATIN, stop date: 25Apr2022; AMITRIPTYLINE; AMLODIPINE; AREDS 2 VISUAL ADVANTAGE; ASPIRIN [ACETYLSALICYLIC ACID]; FOLIC ACID. Past drug history included: Advil, reaction(s): "known allergies: Advil". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a 66 years old female patient with drug allergy to morphine refers to herself. The patient's medical history included pneumonia 5 years ago (in approximately 2007). The patient was vaccinated with PNEUMOVAX 23 (lot # unknown) subcutaneous or intramuscular injection on 05-OCT-2012. No other co-suspects were reported. There were no concomitant medications. On 05-OCT-2012 night, the patient's her injection arm was sore. The upper arm was swollen and very warm to the touch. The swollen moved down to her elbow and she developed a rash. The rash was subsiding, but the arm was still swollen and it was also itched. In addition, she had a headache. The patient had taken ibuprofen and hydrocortisone cream for treatment. The patient sought medical attention by called pharmacist and there was no lab performed for the event. The outcome of her injection arm was sore, headache, the arm itching, the swelling moved down to her elbow, the upper arm was very warm to the touch and the upper arm was swollen was reported as not recovered. Additional information has been requested.
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/16/2023  &  1/21/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
patient passed out after 1 minute of  vaccination . patient gained conscious after 10 seconds. patient threw up after 20 minutes  of waiting. fire department came & checked  on patient. he was find & leave after that.
Myalgia & Fever Narrative: Swelling, localized area of swelling erythema 2 cm at injection site, sore throat, chills. Took day off work, plan to return to work in am if swelling is no worse and symptoms improve.
Patient reported redness, some swelling, warmth, in right arm where prevnar was given. Went to doctor & was diagnosed with cellulitis. Was given a prescription for Keflex. Patient reports improvement after 2 days of antibiotic therapy.
On 2/24/98, the pt developed varicella and sought unspecified medical attention. No further information is available.
Resurgence of depression symptoms thought to have been dealt with. Increased anxiety and feelings of dread/panic.
pt states that one hour post vaccination she developed numbness of the left side of her face and that this lasted until 4-29-2021 when she took benadryl 1 tab 25 mg which seemed to help
At 3PM mother describes a red flush over chest from collar bone to umbilical with itch. No resp. problem, rear red, flushed, left upper arm flushed red where recd. injection
Hive localized to left arm - Malaise, dizziness, general flu symptoms - extreme arm and joint pain.
Patient felt cold, some shortness of breath right after vaccine. Experienced anxiety too. Given water and apple juice - felt better and was discharged to home. Vitals: 168/96, 162/86 (pulse 68). O2 sat 100%.
Received covid-19 booster and experienced flu like symptoms. Symptoms reported by patient. Patient does not consent to follow up.
her blood couldn't stop flowing; My blood was thin; she couldn't make her blood flow normally to take her sample for glucose test; temperature; cough; runny nose; throwing up; This is a spontaneous report from a contactable consumer (patient). A 70-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 3 via an unspecified route of administration on 14Oct2021 (Batch/Lot Number: EW0185) as dose 3 (booster), single (at the age of 70-years-old) for Covid-19 immunisation. Medical history included type 2 diabetic, and cancer. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 14Feb2021 (Batch/Lot Number: EN6200) as dose 1, single (at the age of 69-years-old) for Covid-19 immunisation and had a sore arm and tiredness. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 10Mar2021 (Batch/Lot Number: EN6206) as dose 2, single (at the age of 69-years-old) for Covid-19 immunisation and had a sore arm, tiredness and skin graft and had been hurting. The patient had no or minimal side effect on the first 2 Pfizer shots with a sore arm for a few days and tiredness. The patient recently had a skin graft (19Sep2021) and had been hurting for about a month before the doctor cleared it as the patient was concerned about being on an antibiotic during the hurting as 'it skuts down the immune system'. The patient is type 2 diabetic, controlled alcohol (ALC) in the 5's. After the third shot, in Oct2021, the patient was tested on blood and when they pricked for the dot of blood, the blood was thin, and it did not go to a dot - it ran as the blood couldn't stop flowing. They tried to pull blood in the meter and got an error 4 message over 2 days. The monitor company was contacted, and they said it was blood error to try while they were on the phone. The patient had not tested. She tested the bubble came up that time and got a reading. The incident has never happened in 20 years, probably nothing over. The patient further stated she had temperature, cough, runny nose, and throwing up on an unknown date in 2021. She is a cancer patient and had some problems with her blood after taking the 3rd vaccine. The first two days, she couldn't make her blood flow normally to take her sample for glucose test, and on the third day, her blood couldn't stop flowing. But she is fine now. With her first and second dose she only experienced fatigue. The events 'her blood couldn't stop flowing' and 'she couldn't make her blood flow normally to take her sample for glucose test' resolved in 2021 while the outcome of the rest of the events was unknown.   Follow-up attempts are completed. No further information is expected.
9-26-18 onset; severe back head pain; swelling of glands in neck; stiffness; shakes - told to go to bed for 2 days; 9/28/18 swelling of face - appeared psoriasis was turned into a flare; went to ER - prescribed BENADRYL. 9-30-18 much worse - returned to ER; got high dose of prednisone. Three days psoriasis started to calm down; swelling of face decreased; pains in feet and legs became severe; could hardly walk; this lasted several days; as of 10-16-2018 some pain still in legs (severe foot and leg pain followed by stomach issues that have not resolved).
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles.  The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. Later in 2015, the patient was treated at a hospital for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
A report has been received from an office manager via sales representative concerning a 6 year old female patient who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on 17-Dec-2013. It was reported that the patient was tested positive for flu A on 17-Dec-2013. The patient recovered from the event of tested positive for flu A on an unspecified date. The report was considered to be non-serious. Summary of follow-up information received by AstraZeneca/MedImmune on 07-Jan-2014 from office manager: Lot number and expiry date of the FLUMIST added. Outcome of the event changed to Recovered. Corrected report 17-Jan-2013: Reporter type of the consumer changed to Patient for reporter.
flu like symptoms; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment medications were not provided.
the injected arm swelled; the injected arm swelled and it hurt really bad; shingles on leg; it has come back and it is painful; This non-serious case was reported by a consumer via call center representative and described the occurrence of swelling arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (vaccinated with live Shingles vaccine (Zostavax) 7 to 8 years ago from reporting).   In FEB-2023, the patient received the 1st dose of Shingrix (unknown arm). On 24-MAY-2023, between 2 and 4 months after receiving Shingrix, the patient experienced pain (Verbatim: it has come back and it is painful). On an unknown date, the patient experienced swelling arm (Verbatim: the injected arm swelled), pain in arm (Verbatim: the injected arm swelled and it hurt really bad) and shingles (Verbatim: shingles on leg). The patient was treated with medication unknown (Cream (Medication Unknown)). The outcome of the swelling arm and pain in arm were resolved and the outcome of the shingles and pain were not resolved.   The reporter considered the swelling arm and pain in arm to be related to Shingrix. It was unknown if the reporter considered the shingles and pain to be related to Shingrix.     The company considered the swelling arm and pain in arm to be related to Shingrix. It was unknown if the company considered the shingles and pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 26-MAY-2023 The case was self-reported by the patient. The patient received first dose of Shingrix about 3 months ago from reporting and reported that the injected arm swelled, and it hurt really bad. Two or three weeks later, the patient broke out in shingles on her leg. The patient went to the doctor, and he said it looks like shingles and he prescribed a cream, and it cleared up.  The patient stated that her doctor did not want her to get Shingrix second shot. Now, she was experiencing a similar situation with her other leg. The patient had it on other leg and it had come back, and it was painful.  The patient had not yet seen a doctor about this because it only began 2 days ago. Therefore, she did not know for sure it was shingles again. But she said it covers a big portion of her leg and she was using an unspecified cream and she was going to get Benadryl if it itches. No further information was collected due to a poor phone connection.
This spontaneous report as received from a physician refers to his 72 year old wife. On 04-FEB-2013, the patient was vaccinated with a dose of PNEUMOVAX23 (Lot # not reported) intramuscularly. The physician reported that on 05-FEB-2013, the patient developed a lump in her arm at the site of the PNEUMOVAX23 vaccination. The lump in the arm was traveling down her arm to her elbow. There were no Lab diagnosis or studies performed. The outcome of lump in her arm at the site of vaccination was reported as not recovered/not resolved. Additional information has been requested.
N/A. Gave wrong administered vaccine. Gave Dtap instead of Tdap.
cellulitis, redness, edema rt upper outer arm 6x8inches;red, hot & hard;pain in t arm pit lymph nodes;t103.5 on 9/25/99, would only decrease to 101.9-102 taking analgesics to cool baths;nausea w/dry heaves, swelling redness & heat resolved;
pt exp generalized convuls lasting 1 or 2 min; no cyanosis; no incontinence; seen 24 hrs p/DPT; seen by MD PE neg; no more DTP just DT;
the vaccine made me pretty ill; rash; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (the vaccine made me pretty ill), RASH (rash) and PYREXIA (fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (the vaccine made me pretty ill), RASH (rash) and PYREXIA (fever). At the time of the report, ILLNESS (the vaccine made me pretty ill), RASH (rash) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Shingrix -50 mcg Sore am muscle, red, swelling in area, whole body broke out, looked like sun burn and blotchy, whole body itching.
This spontaneous report was received from a medical assistant, referring to about 3 patients. Ages, genders, medical history or concurrent conditions were not reported. On 05-DEC-2015, doses of M-M-R II (lot # L024267, rHA, expiration date 01-JUL-2017) were improperly exposed to 19C for 23  hours, then on unspecified dates between 05-DEC-2015 and 05-JAN-2016, about 3 patients each received a dose of this improperly exposed M-M-R II. No known adverse effects have been reported. The reporter stated that was not product quality complaints involved. Additional information has been requested.
THE FOLLOWING SYMPTONS BEGAN ON 5/19/2021 AND COME AND GO PERIODICALLY: GENERAL MALAISE, HEADACHE, FATIGUE, NUMBNESS IN LEFT ARM AND FACE, DIZZINESS, LOSS OF BALANCE.  ON THE MORNING OF 6/8/2021 I WENT TO MY FAMILY PHYSICIAN AND THEY SENT ME TO THE ER FOR THE POSSIBILITY OF A STROKE.  I WAS ADMITTED TO THE HOSPITAL AND AFTER NUMEROUS TESTS, A STROKE WAS RULED OUT. I WAS DISCHARGED THE EVENING OF 6/9/2021 WITH NO DIAGNOSIS.  ALSO I WAS GIVEN A HEART MONITOR THAT I HAD TO WEAR FOR TWO WEEKS AND RESULTS WERE NEGATIVE.
Fell asleep for 8-9 hours after vaccine and woke up unable to talk. She struggles with forming words and speaking entirely. She closes her eyes and takes deep breathes when trying to talk, and words come out slurred or not baseline for her speech.